0001209191-18-055456.txt : 20181017 0001209191-18-055456.hdr.sgml : 20181017 20181017194442 ACCESSION NUMBER: 0001209191-18-055456 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181017 FILED AS OF DATE: 20181017 DATE AS OF CHANGE: 20181017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zeneca, Inc. CENTRAL INDEX KEY: 0001657583 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38697 FILM NUMBER: 181127365 BUSINESS ADDRESS: STREET 1: 1800 CONCORD PIKE CITY: WILMINGTON STATE: DE ZIP: 19803 BUSINESS PHONE: 800-236-9933 MAIL ADDRESS: STREET 1: 1800 CONCORD PIKE CITY: WILMINGTON STATE: DE ZIP: 19803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ASTRAZENECA PLC CENTRAL INDEX KEY: 0000901832 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38697 FILM NUMBER: 181127366 BUSINESS ADDRESS: STREET 1: 1 FRANCIS CRICK AVENUE STREET 2: CAMBRIDGE BIOMEDICAL CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB2 0AA BUSINESS PHONE: 011 44 20 7304 5000 MAIL ADDRESS: STREET 1: 1 FRANCIS CRICK AVENUE STREET 2: CAMBRIDGE BIOMEDICAL CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB2 0AA FORMER NAME: FORMER CONFORMED NAME: ZENECA GROUP PLC DATE OF NAME CHANGE: 19930422 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc CENTRAL INDEX KEY: 0001169245 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 030375697 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (610) 981-6500 MAIL ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: Phase Biosciences Inc DATE OF NAME CHANGE: 20061013 FORMER COMPANY: FORMER CONFORMED NAME: DT BIOSCIENCES INC DATE OF NAME CHANGE: 20020315 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2018-10-17 0 0001169245 PhaseBio Pharmaceuticals Inc PHAS 0000901832 ASTRAZENECA PLC 1 FRANCIS CRICK AVENUE CAMBRIDGE X0 CB2 0AA UNITED KINGDOM 0 0 1 0 0001657583 Zeneca, Inc. C/O ASTRAZENECA PLC 1 FRANCIS CRICK AVENUE CAMBRIDGE X0 CB2 0AA UNITED KINGDOM 0 0 1 0 Series C-1 Preferred Stock Common Stock 1553060 I By Zeneca, Inc. Series D Preferred Stock Common Stock 740337 I By Zeneca, Inc. Warrants to Purchase Series C-1 Preferred Stock 0.12 Series C-1 Preferred Stock 113891 I By Zeneca, Inc. Each share of Preferred Stock is convertible at any time at the option of the holder into Common Stock on a one-for-one basis, has no expiration date and will convert into shares of Common Stock upon the closing of the Issuer's initial public offering. Zeneca, Inc. is a wholly-owned subsidiary of AstraZeneca PLC. AstraZeneca PLC may be deemed to beneficially own the securities held by Zeneca, Inc., but disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, if any. The warrants are immediately exercisable and terminate upon the closing of the Issuer's initial public offering. /s/ Marc Dunoyer, on behalf of AstraZeneca PLC 2018-10-17 /s/ David E. White, on behalf of Zeneca, Inc. 2018-10-17